| Product Code: ETC9524527 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Suriname market for valganciclovir import shipments in 2024 continued to be dominated by top exporting countries such as Netherlands, India, Germany, Hong Kong, and Guyana. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market structure. Despite a modest Compound Annual Growth Rate (CAGR) of 2.21% from 2020 to 2024, there was a slight acceleration in growth with a 2.02% rate in 2024 compared to the previous year. This data suggests a stable market with consistent import activity in Suriname for valganciclovir.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Valganciclovir Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Valganciclovir Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Valganciclovir Market - Industry Life Cycle |
3.4 Suriname Valganciclovir Market - Porter's Five Forces |
3.5 Suriname Valganciclovir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Valganciclovir Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Suriname Valganciclovir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cytomegalovirus (CMV) infections in Suriname |
4.2.2 Growing awareness and adoption of antiviral medications like valganciclovir |
4.2.3 Government initiatives to improve healthcare infrastructure and access to medications |
4.3 Market Restraints |
4.3.1 High cost of valganciclovir treatment |
4.3.2 Limited availability and accessibility of specialized healthcare facilities for CMV treatment |
5 Suriname Valganciclovir Market Trends |
6 Suriname Valganciclovir Market, By Types |
6.1 Suriname Valganciclovir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Valganciclovir Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Valganciclovir Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.4 Suriname Valganciclovir Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2 Suriname Valganciclovir Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Valganciclovir Market Revenues & Volume, By Adults, 2021- 2031F |
6.2.3 Suriname Valganciclovir Market Revenues & Volume, By Children, 2021- 2031F |
7 Suriname Valganciclovir Market Import-Export Trade Statistics |
7.1 Suriname Valganciclovir Market Export to Major Countries |
7.2 Suriname Valganciclovir Market Imports from Major Countries |
8 Suriname Valganciclovir Market Key Performance Indicators |
8.1 Number of new CMV cases diagnosed annually in Suriname |
8.2 Percentage increase in prescriptions of valganciclovir over the past year |
8.3 Patient adherence rate to valganciclovir treatment plan |
9 Suriname Valganciclovir Market - Opportunity Assessment |
9.1 Suriname Valganciclovir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Valganciclovir Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Suriname Valganciclovir Market - Competitive Landscape |
10.1 Suriname Valganciclovir Market Revenue Share, By Companies, 2024 |
10.2 Suriname Valganciclovir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |